CompletedPhase 2NCT00245102

Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma

Studying Angiosarcoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
National Cancer Institute (NCI)
Principal Investigator
Robert Maki, MD, PhD
Memorial Sloan Kettering Cancer Center
Intervention
sorafenib tosylate(drug)
Enrollment
147 enrolled
Eligibility
18 years · All sexes
Timeline
2005 – 2011

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00245102 on ClinicalTrials.gov

Other trials for Angiosarcoma

Additional recruiting or active studies for the same condition.

See all trials for Angiosarcoma →

← Back to all trials